These cells include CD4 FOXP3+ regulatory T cells (Tregs), tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs); all these subsets are capable of inhibiting effector T cell anti-tumor immune response, although with different mechanisms. Here, FOXP3 is linked to neoplasm.